Publication | Open Access
Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years
32
Citations
28
References
2023
Year
Among the study patients, ICL continued to be associated with increased susceptibility to viral, encapsulated fungal, and mycobacterial diseases, as well as with a reduced response to novel antigens and an increased risk of cancer. (Funded by the National Institute of Allergy and Infectious Diseases and the National Cancer Institute; ClinicalTrials.gov number, NCT00867269.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1